Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Filings indexed 1,245 across all filing types
Latest filing 2022-07-27 Regulatory Filings
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the intimation of loss of share certificate and the issuance of a duplicate share certificate. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs such notifications. The content is about a specific shareholder's lost share certificate and the procedural update to the exchanges. This is a regulatory announcement related to share certificates and does not contain financial data, management discussion, or report publication. It is not a financial report, earnings release, or management information. It fits best under Regulatory Filings (RNS) as a compliance notification to the stock exchanges.
2022-07-27 English
Loss of share certificate
Major Shareholding Notification Classification · 85% confidence The document contains a table listing shareholders with folio numbers, share certificate numbers, and number of shares. It appears to be a record of shareholdings or share certificates. There is no indication of a report, announcement, or regulatory filing. The document is very short (378 characters) and does not contain financial data, management information, or voting results. It is most consistent with a Major Shareholding Notification or a similar share ownership disclosure. Given the content, the best fit is Major Shareholding Notification (MRQ).
2022-07-21 English
Newspaper Advertisements
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data including standalone and consolidated financial results for the quarter ended June 30, 2022, with comparative figures for previous quarters and years. It includes profit, income, earnings per share, and notes explaining provisions, legal matters, and accounting treatments. The document references approval by the Board of Directors and review by the audit committee, indicating it is a formal financial report. The presence of comprehensive financial statements and analysis for a quarter strongly indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2022-07-21 English
Communication to shareholders as per Reg 30
Regulatory Filings Classification · 95% confidence The document is a notice to shareholders regarding the compulsory transfer of unclaimed final dividend shares to the Investor Education and Protection Fund (IEPF) Authority. It references regulatory requirements under the Companies Act, 2013 and SEBI Listing Obligations, and details the process and deadlines for shareholders to claim their shares or dividends before transfer. The content is an official announcement to shareholders about dividend and share transfer procedures, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. The document is a regulatory announcement related to shareholder rights and compliance with statutory rules, fitting best under the category of Regulatory Filings (RNS).
2022-07-21 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about informing the exchanges of a shareholder's request for duplicate share certificates due to loss, which is a regulatory compliance announcement rather than a financial report or management update. The document length is short (2861 characters) and does not contain financial data, earnings, management discussion, or meeting materials. It is not an announcement of voting results, capital changes, or insider dealings. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-07-21 English
In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of newspaper advertisement of notice published in ....
Regulatory Filings
2022-07-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.